Need a specific person's email?
Browse Genalyte, Inc.'s employee directory (about 94 employees) and reveal verified emails free.
Genalyte, Inc.'s most common email format is First.Last@genalyte.com (ex. John.Doe@genalyte.com), used for 42% of genalyte.com addresses. Genalyte, Inc. uses 7 email patterns across 2 domains: genalyte.com and tel.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of genalyte.com |
|---|---|---|
| First.Last@genalyte.comMost common | John.Doe@genalyte.com | |
| First@genalyte.com | John@genalyte.com | |
| Last@genalyte.com | Doe@genalyte.com | |
| FirstLast@genalyte.com | JohnDoe@genalyte.com |
| Format | Example | Share of tel.com |
|---|---|---|
| First.Last@tel.comMost common | John.Doe@tel.com | |
| FLast@tel.com | JDoe@tel.com | |
| Last.First@tel.com | Doe.John@tel.com |
Browse Genalyte, Inc.'s employee directory (about 94 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States51-200 Employees
Genalyte, Inc. is a biotechnology research company located in San Diego, California, at 6620 Mesa Ridge Road, 92121. The company employs between 51 and 200 people. Genalyte delivers real-time, point-of-care blood diagnostics and analytics, with a website at genalyte.com. It has developed SARS-CoV-2 diagnostics, including a SARS-CoV-2 Multi-Antigen Serology Panel, and received FDA Emergency Use Authorization for a rapid COVID-19 antibody test in 2020. The company has engaged in financing rounds and partnerships, including Verily as lead investor in a 2021 round and a strategic partnership with Burjeel Holdings announced in 2025 at Abu Dhabi Global Health Week. Revenue is reported in the range of $25 million to $50 million, and the company has raised funding.
Most common format
First.Last@genalyte.com
Example: John.Doe@genalyte.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.